Merck’s Keytruda is cleared in Europe as adjuvant therapy in kidney cancer
January 27 2022 - 7:03AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2024 to May 2024
Merck (NYSE:MRK)
Historical Stock Chart
From May 2023 to May 2024